Alexion Pharmaceuticals Inc

ALXN 
(NASDAQ) 
 
$ 124,52
Opdateret 00:52:27
Ændring % 0,00% Aktiekurs uændret
Ændring 0,00 Aktiekurs uændret
Volume 375.211
Høj $ 124,76
Lav $ 121,86
Åben $ 122,39
ISIN
Seneste luk $ 121,91
# af aktier 222,50M
Markedsværdi 27.706M USD
I dag

Market closed
Alexion Pharmaceuticals Inc
Markedet er lukket, åbner klokken 15:30
 
Kursudvikling Seneste 1 uge 1 måned 3 mdr 6 mdr 1 år
 
  124,52 3,6% Stigning i aktiekurs 4,3% Stigning i aktiekurs 5,6% Stigning i aktiekurs 5,3% Stigning i aktiekurs 0,8% Stigning i aktiekurs
Powered by TradingView

Firmaprofil

Alexion Pharmaceuticals specializes in developing and marketing drugs for life-threatening medical conditions. Its blockbuster product is Soliris, which is the only approved therapy for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome, two ultra-rare blood disorders, and was recently approved in general myasthenia gravis. Strensiq and Kanuma target other ultra-rare metabolic diseases. Alexion's pipeline targets areas of high unmet need and complement-mediated disorders.

Copyright Euroinvestor A/S 2018  Disclaimer  |  Cookie- og privatlivspolitik  |  Persondatapolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
21. juni 2018 10:07:24
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180619.1 - EUROWEB2 - 2018-06-21 10:07:24 - 2018-06-21 10:07:24 - 1 - Website: OKAY